The updated ATS/ERS spirometry technical standards.
Paul J Nicholson
https://pubmed.ncbi.nlm.nih.gov/32073625/Actively Recruiting
Led by LASARRUS Clinic and Research Center · Updated on 2025-09-09
128
Participants Needed
2
Research Sites
4 weeks
Total Duration
Researchers are evaluating the WearME systems effectiveness in monitoring the severity and respiratory function of people with Chronic Obstructive Pulmonary Disease COPD. This observational study compares the systems measurements with standard clinical assessments such as spirometry and capnography. The study aims to provide innovative technology access to underserved patients in low-income, rural, and diverse ethnic communities in the Mid-Atlantic region to help detect early signs of worsening lung function and reduce hospital readmissions. Participants will wear the WearME device during a data collection session lasting 145 minutes. The study will assess parameters including forced expiratory volume FEV1, forced vital capacity FVC, respiratory rate, heart rate, inspiratory to expiratory IE ratio, spinal range of motion ROM, and activity levels. The WearME-Pro systems measurements will be compared to gold standard FDA-cleared devices used in clinical practice. Up to 128 COPD patients will be grouped by severity using the GOLD standard and monitored simultaneously with the WearME-Basic and WearME-Pro systems. During the study, participants will wear the device while undergoing reference testing with standard medical devices. Researchers will evaluate the agreement between WearME-Pro and standard devices for lung function measures and validate the WearME-Basic system for vital signs and activity accuracy. The primary outcome focuses on the agreement of FEV1FVC measurements, with secondary outcomes assessing respiration rate, heart rate, IE ratio, and ROM accuracy. The total participation involves a single data collection period and associated clinical assessments, with monitoring conducted within six months of study start.
CONDITIONS
Effectiveness of the WearME System for COPD Severity and Respiratory Function
L
Lloyd E Emokpae, PhD.
R
Roland N Emokpae, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
LASARRUS Clinic and Research Center
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 145 minutes
Participants wear the WearME device and undergo reference testing to assess lung function and activity biomarkers.
1 visit (in-person)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Paul J Nicholson
https://pubmed.ncbi.nlm.nih.gov/32073625/Anders Løkke, Peter Lange, Jesper Lykkegaard...
https://pubmed.ncbi.nlm.nih.gov/33731990/GBD Chronic Respiratory Disease Collaborators
https://pubmed.ncbi.nlm.nih.gov/32526187/LASARRUS Clinic and Research Center
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor